DAIC Articles

Sep 2, 2019 | DAIC Articles
Lifelong Exposure to Lower LDL and BP Linked With Big Reduction in CVD Events

PARIS, France—Genetic predisposition to lower LDL cholesterol and systolic blood pressure levels over the course of a lifetime are associated with a lower risk of cardiovascular disease, new research shows. Importantly, even relatively small reductions in these two risk factors yields a significant boost in terms of cardiovascular disease prevention.

Aug 24, 2019 | DAIC Articles
Image-based FFR May Replace Pressure Wires and Adenosine

New technologies have been developed that may replace the traditional pressure wires and adenosine to assess the fractional flow reserve (FFR). This includes image-derived FFR, such as noninvasive computed tomography imaging derived FFR (FFR-CT), and X-ray angiography derived FFR (FFR-angio) that can be performed while the patient is on the table in the cath lab.

Aug 23, 2019 | DAIC Articles
Cook Medical Launches 2.6 Fr CXI Support Catheter

August 23, 2019 — Cook Medical recently released the second generation of the 2.6 Fr CXI Support Catheter with platinum-iridium marker bands. The CXI catheter is used in small-vessel anatomy or superselective anatomy for diagnostic and interventional procedures, including peripheral use.

Aug 23, 2019 | DAIC Articles
Recent Advances in Interventional Guidewire Technology

Guidewire engineering has become more advanced over the past decade as interventional cardiologists have advanced their trade to tackle much more complex lesions, including chronic total occlusions (CTO).

Aug 22, 2019 | DAIC Articles
Edwards Recalls Sapien 3 Ultra Delivery System Due to Burst Balloons During Surgery

August 22, 2019 — Edwards Lifesciences is recalling the Sapien 3 Ultra delivery system after receiving reports of burst balloons during implantation procedures, which have resulted in significant difficulty retrieving the valve into the catheter and withdrawing the system from the patient. The company said this may cause vascular injury, bleeding or surgical intervention.

Aug 22, 2019 | DAIC Articles
Global Cardiovascular Stent Market Poised for Almost 7 Percent Growth Through 2025

August 21, 2019 — Increasing incidence of cardiovascular diseases worldwide is creating growth opportunities for the global cardiovascular stents market, predicts Fortune Business Insights in a new study.

Aug 21, 2019 | DAIC Articles
Jackson Memorial Hospital Holds Ribbon-cutting for New Cardiac Catheterization Labs

August 21, 2019 — Jackson Memorial Hospital in Miami celebrated the opening of two newly renovated cardiac catheterization suites during a ribbon-cutting ceremony on August 19, 2019. The suites feature the new Alphenix Core+ from Canon Medical Systems, which provides diverse imaging without compromising image quality or performance. Jackson Memorial is the first hospital in Florida offering […]

Aug 14, 2019 | DAIC Articles
Ancora Heart Enrolls First Patient in European Multi-center Study of AccuCinch Heart Failure Therapy

August 14, 2019 — Ancora Heart Inc. announced the first patient was enrolled in the CorCinch EU study, a European multi-center clinical evaluation of the AccuCinch Ventricular Repair System as a treatment for patients with reduced ejection fraction systolic heart failure (HFrEF).

Aug 14, 2019 | DAIC Articles
Concept Medical Granted FDA Breakthrough Device Designation for MagicTouch PTA Sirolimus Coated Balloon

August 14, 2019 — Concept Medical Inc. (CMI) has been granted “Breakthrough Device Designation” from the U.S. Food and Drug Administration (FDA) for MagicTouch PTA, its sirolimus drug coated balloon (DCB) catheter, for the treatment of peripheral artery disease (PAD) in below-the-knee (BTK) applications.

Aug 12, 2019 | DAIC Articles
National Coverage Determination Will Make TAVR Available to More Patients at More Centers

As we usher in a new era for treating patients with aortic stenosis, we have been reflecting on the evolution of the technology used for transcatheter aortic valve replacement (TAVR) and the evolution of our collaborative process as a team over years as a center in the PARTNER 3 clinical trial. PARTNER 3, which this […]

X